Platelet proteome in healthy volunteers who smoke

References

• Doyle JT, Dawber TR, Kannel WB, Heslin AS, Kahn HA. Cigarette smoking and coronary heart disease. N Engl J Med 1962; 266: 796–801
   PubMed Web of Science ®Google Scholar
• Armani C, Landini L, Jr, Leone A. Molecular and biochemical changes of the cardiovascular system due to smoking exposure. Curr Pharm Des 2009; 15: 1038–1053
   PubMed Web of Science ®Google Scholar
• Schroeter MR, Sawalich M, Humboldt T, Leifheit M, Meurrens K, Berges A, Xu H, Lebrun S, Wallerath T, Konstantinides S, et al. Cigarette smoke exposure promotes arterial thrombosis and vessel remodeling after vascular injury in apolipoprotein E-deficient mice. J Vasc Res 2008; 45: 480–492
   PubMedGoogle Scholar
• Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 2004; 43: 1731–1737
   PubMed Web of Science ®Google Scholar
• Petitti DB, Kipp H. The leukocyte count: Associations with intensity of smoking and persistence of effect after quitting. Am J Epidemiol 1986; 123: 89–95
   PubMed Web of Science ®Google Scholar
• Calapai G, Caputi AP, Mannucci C, Gregg EO, Pieratti A, Aurora Russo G, Chaudhary N, Puntoni R, Lowe F, McEwan M, et al. A cross-sectional investigation of biomarkers of risk after a decade of smoking. Inhal Toxicol 2009; 21: 1138–1143
   PubMed Web of Science ®Google Scholar
• Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: Is it time to intervene?. Arterioscler Thromb Vasc Biol 2005; 25: 658–670
   PubMed Web of Science ®Google Scholar
• Cerletti C, Evangelista V, de Gaetano G. P-selectin-beta 2-integrin cross-talk: A molecular mechanism for polymorphonuclear leukocyte recruitment at the site of vascular damage. Thromb Haemost 1999; 82: 787–793
   PubMed Web of Science ®Google Scholar
• Glynn MF, Mustard JF, Buchanan MR, Murphy EA. Cigarette smoking and platelet aggregation. Can Med Assoc J 1966; 95: 549–553
   PubMedGoogle Scholar
• Levine PH. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation 1973; 48: 619–623
   PubMed Web of Science ®Google Scholar
• Ring T, Kristensen SD, Jensen PN, Mourits-Andersen T, Madsen H, Dyerberg J. Cigarette smoking shortens the bleeding time. Thromb Res 1983; 32: 531–536
   PubMed Web of Science ®Google Scholar
• Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y. Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 1999; 93: 271–278
   PubMed Web of Science ®Google Scholar
• Nair S, Kulkarni S, Camoens HM, Ghosh K, Mohanty D. Changes in platelet glycoprotein receptors after smoking – a flow cytometric study. Platelets 2001; 12: 20–26
   PubMed Web of Science ®Google Scholar
• Neubauer H, Setiadi P, Pinto A, Günesdogan B, Meves SH, Börgel J, Mügge A. Upregulation of platelet CD40, CD40 ligand (CD40L) and P-Selectin expression in cigarette smokers: A flow cytometry study. Blood Coagul Fibrinolysis 2009; 20: 694–698
   PubMed Web of Science ®Google Scholar
• Böck M, De Haan J, Beck KH, Gutensohn K, Hertfelder HJ, Karger R, Heim MU, Beeser H, Weber D, Kretschmer V. Standardization of the PFA-100(R) platelet function test in 105 mmol/l buffered citrate: Effect of gender, smoking, and oral contraceptives. Br J Haematol 1999; 106: 898–904
   PubMed Web of Science ®Google Scholar
• Jastrzebska M, Chełstowski K, Mierzecki A, Klimek K, Bukowska H. Effects of fenofibrate treatment on prothrombotic state in patients with metabolic syndrome in relation to smoking and diabetes. Med Sci Monit 2009; 15: PI27–P133
   PubMedGoogle Scholar
• Garlichs CD, Cicha I, Raaz D, Meyer L, Stumpf C, Klinghammer L, Yilmaz A, Daniel WG. CD40/CD154 system and pro-inflammatory cytokines in young healthy male smokers without additional risk factors for atherosclerosis. Inflamm Res 2009; 58: 306–311
   PubMed Web of Science ®Google Scholar
• Banfi C, Brioschi M, Marenzi G, De Metrio M, Camera M, Mussoni L, Tremoli E. Proteome of platelets in patients with coronary artery disease. Exp Hematol 2010; 38: 341–350
   PubMed Web of Science ®Google Scholar
• Mateos-Cáceres PJ, Macaya C, Azcona L, Modrego J, Mahillo E, Bernardo E, Fernandez-Ortiz A, López-Farré AJ. Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients. Thromb Haemost 2010; 103: 160–170
   PubMed Web of Science ®Google Scholar
• Krishnan S, Gaspari M, Della Corte A, Bianchi P, Crescente M, Cerletti C, Torella D, Indolfi C, de Gaetano G, Donati MB, et al. OFFgel-based multidimensional LC-MS/MS approach to the cataloguing of the human platelet proteome for an interactomic profile. Electrophoresis 2011;32:686–695
   Google Scholar
• Finamore F, Pieroni L, Ronci M, Marzano V, Mortera SL, Romano M, Cortese C, Federici G, Urbani A. Proteomics investigation of human platelets by shogun nUPLC-MSE and 2DE experimental strategies: A comparative study. Blood Transfus 2010; 8(Suppl. 3)s140–s148
   Google Scholar
• D'Alessandro A, Righetti PG, Zolla L. The red blood cell proteome and interactome: An update. J Proteome Res 2010; 9: 144–163
   PubMed Web of Science ®Google Scholar
• Della Corte A, Maugeri N, Pampuch A, Cerletti C, de Gaetano G, Rotilio D. Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretome. Platelets 2008; 19: 43–50
   PubMed Web of Science ®Google Scholar
• Zellner M, Winkler W, Hayden H, Diestinger M, Eliasen M, Gesslbauer B, Miller I, Chang M, Kungl A, Roth E, et al. Quantitative validation of different protein precipitation methods in proteome analysis of blood platelets. Electrophoresis 2005; 26: 2481–2489
   PubMed Web of Science ®Google Scholar
• Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000; 21: 1037–1053
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg YJ. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Royal Statist Soc B 1995; 57: 289–300
   Google Scholar
• Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 5: 850–858
   Google Scholar
• Di Michele M, Marcone S, Cicchillitti L, Della Corte A, Ferlini C, Scambia G, Donati MB, Rotilio D. Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: Towards the identification of putative biomarkers. J Proteomics 2010; 73: 879–898
   PubMed Web of Science ®Google Scholar
• Di Michele M, Della Corte A, Cicchillitti L, Del Boccio P, Urbani A, Ferlini C, Scambia G, Donati MB, Rotilio D. A proteomic approach to paclitaxe chemoresistance in ovarian cancer cell lines. Biochim Biophys Acta 2009; 1794: 225–236
   PubMedGoogle Scholar
• D'Imperio M, Della Corte A, Facchiano A, Di Michele M, Ferrandina G, Donati MB, Rotilio D. Standardized sample preparation phases for a quantitative measurement of plasma peptidome profiling by MALDI-TOF. J Proteomics 2010; 73: 1355–1367
   PubMed Web of Science ®Google Scholar
• Maugeri N, Donati MB, de Gaetano G, Cerletti C. Formation of mixed platelet-PMN leukocyte aggregates in the platelet function analyzer (PFA-100) device. Thromb Haemost 2007; 97: 156–157
   PubMedGoogle Scholar
• Hayward CP, Harrison P, Cattaneo M, Ortel TL, Rao AK. Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4: 312–319
   PubMed Web of Science ®Google Scholar
• Izzi B, Pampuch A, Costanzo S, Vohnout B, Iacoviello L, Cerletti C, de Gaetano G. Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood. Thromb Haemost 2007; 98: 1276–1284
   PubMed Web of Science ®Google Scholar
• Bereczky Z, Muszbek L. Factor XIII and venous thromboembolism. Semin Thromb Hemost 2011; 37: 305–314
   PubMedGoogle Scholar
• Serrano K, Devine DV. Intracellular factor XIII crosslinks platelet cytoskeletal elements upon platelet activation. Thromb Haemost 2002; 88: 315–320
   PubMedGoogle Scholar
• Haustein KO, Krause J, Haustein H, Rasmussen T, Cort N. Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. J Intern Med 2002; 252: 130–139
   PubMedGoogle Scholar
• Magwenzi SG, Ajjan RA, Standeven KF, Parapia LA, Naseem KM. Factor XIII supports platelet activation and enhances thrombus formation by matrix proteins under flow conditions. J Thromb Haemost 2011; 9: 820–833
   PubMed Web of Science ®Google Scholar
• Ariëns RA, Kohler HP, Mansfield MW, Grant PJ. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol 1999; 19: 2012–2016
   PubMedGoogle Scholar
• Muszbek L, Bereczky Z, Bagoly Z, Shemirani AH, Katona E. Factor XIII and atherothrombotic diseases. Semin Thromb Hemost 2010; 36: 18–33
   PubMedGoogle Scholar
• Barua RS, Sy F, Srikanth S, Huang G, Javed U, Buhari C, Margosan D, Ambrose JA. Effects of cigarette smoke exposure on clot dynamics and fibrin structure: An ex vivo investigation. Arterioscler Thromb Vasc Biol 2010; 30: 75–79
   PubMedGoogle Scholar
• Undas A, Topór-Madry R, Tracz W, Pasowicz M. Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis. Thromb Haemost 2009; 102: 1289–1291
   PubMed Web of Science ®Google Scholar
• Iacoviello L, Bonanni A, Costanzo S, De Curtis A, Di Castelnuovo A, Olivieri M, Zito F, Donati MB, de Gaetano G. On behalf of the Moli-sani Project Investigators. The Moli-Sani Project, a randomized, prospective cohort study in the Molise region in Italy; design, rationale and objectives. Italian J Public Health 2007; 4: 110–118
   Google Scholar
• De Curtis A, Magnacca S, Marracino F, Costanzo S, Zito F, Di Castelnuovo A, Arcari A, Rago L, Di Giuseppe R, Persichillo M, et al. D-Dimer levels and risk factors for cardiovascular disease in a general adult Italian population: Results from the Moli-sani study. Haematologica 2008; 93(s3)16 (Abst C048)
   Google Scholar
• Dardik R, Shenkman B, Tamarin I, Eskaraev R, Harsfalvi J, Varon D, Inbal A. Factor XIII mediates adhesion of platelets to endothelial cells through alpha(v)beta(3) and glycoprotein IIb/IIIa integrins. Thromb Res 2002; 105: 317–323
   PubMed Web of Science ®Google Scholar
• Dardik R, Solomon A, Loscalzo J, Eskaraev R, Bialik A, Goldberg I, Schiby G, Inbal A. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression. Arterioscler Thromb Vasc Biol 2003; 23: 1472–1477
   PubMed Web of Science ®Google Scholar
• White JG. Morphology and ultrastructure of platelets. Platelets in Thrombotic and Non-thrombotic Disorders, P Gresele, CP Page, V Fuster, J Vermylen. Cambridge University Press, Cambridge 2002; 41–69
   Google Scholar
• Pieroni L, Finamore F, Ronci M, Mattoscio D, Marzano V, Mortera SL, Quattrucci S, Federici G, Romano M, Urbani A. Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: A comparative study. Mol Biosyst 2011; 7: 630–639
   PubMed Web of Science ®Google Scholar
• Kile BT, Panopoulos AD, Stirzaker RA, Hacking DF, Tahtamouni LH, Willson TA, Mielke LA, Henley KJ, Zhang JG, Wicks IP, et al. Mutations in the cofilin partner Aip1/Wdr1 cause autoinflammatory disease and macrothrombocytopenia. Blood 2007; 110: 2371–2380
   PubMed Web of Science ®Google Scholar
• Joly AL, Wettstein G, Mignot G, Ghiringhelli F, Garrido C. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. J Innate Immun 2010; 2: 238–247
   PubMed Web of Science ®Google Scholar
• Polanowska-Grabowska R, Gear AR. Heat-shock proteins and platelet function. Platelets 2000; 11: 6–22
   PubMedGoogle Scholar
• Beere HM. Death versus survival: Functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 2005; 115: 2633–2639
   PubMed Web of Science ®Google Scholar
• Jawa RS, Anillo S, Huntoon K, Baumann H, Kulaylat M. Analytic review: Interleukin-6 in surgery, trauma, and critical care: Part I: Basic science. J Intensive Care Med 2011; 26: 3–12
   PubMedGoogle Scholar
• Gobert AP, Bambou JC, Werts C, Balloy V, Chignard M, Moran AP, Ferrero RL. Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a toll-like receptor (TLR)-2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism. J Biol Chem 2004; 279: 245–250
   PubMed Web of Science ®Google Scholar
• Steele BM, Harper MT, Macaulay IC, Morrell CN, Perez-Tamayo A, Foy M, Habas R, Poole AW, Fitzgerald DJ, Maguire PB. Canonical Wnt signaling negatively regulates platelet function. Proc Natl Acad Sci USA 2009; 106: (1983)6–19841
   Google Scholar